Free Access
| Issue |
Med Sci (Paris)
Volume 21, Number 1, Janvier 2005
|
|
|---|---|---|
| Page(s) | 28 - 29 | |
| Section | Nouvelles | |
| DOI | https://doi.org/10.1051/medsci/200521128 | |
| Published online | 15 January 2005 | |
- Sperling RS, Shapiro DE, Coombs RW, et al. Maternal viral load, zidovudine treatment, and the risk of transmission of human immunodeficiency virus type 1 from mother to infant. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group. N Engl J Med 1996; 335 : 1621–9. [Google Scholar]
- Jourdain G, Ngo-Giang-Huong N, Le Coeur S, et al. Intrapartum exposure to nevirapine and subsequent maternal responses to nevirapine-based antiretroviral therapy. N Engl J Med 2004; 351 : 229–40. [Google Scholar]
- World Health Organization. Antiretroviral drugs for treating pregnant women and preventing HIV infection in infants. Guidelines on care, treatment and support for women living with HIV/AIDS and their children in resource-constrained settings. Genève : OMS, 2004 : 50 p. http://www.who.int/3by5/arv_pmtct/en/. [Google Scholar]
- McIntyre J, Martinson N and Investigators for the Trial 1413. Addition of short course combivir (CBV) to single dose viramune (sdNVP) for prevention of mother-to-child transmission (MTCT) of HIV-1 can significantly decrease the subsequent development of maternal NNRT-resistant virus. Bangkok : XVe Conférence Internationale sur le Sida, juillet 2004, LbOrB09. [Google Scholar]
Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.
Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.
Initial download of the metrics may take a while.